| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |